The present invention relates to compounds of the Formulae (I) and (II), wherein R
1
—R
10
and G are defined herein, and their pharmaceutically acceptable salts. These compounds modulate the activity of c-Met and are therefore expected to be useful in the prevention and treatment of c-Met related disorders such as cancer.